Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1163)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,999
Price
$25.25
Total Value
$151.47K
Shares Held After
383,684
% of Holdings
1.5%
Rapport Therapeutics, Inc. (RAPP)
Ignelzi Troy A. — Chief Financial Officer
Shares
5,500
Price
$26.10
Total Value
$143.55K
Shares Held After
15,500
% of Holdings
35.5%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
266
Price
$80.23
Total Value
$21.34K
Shares Held After
12,991
% of Holdings
2.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
11,470
Price
$80.23
Total Value
$920.24K
Shares Held After
293,430
% of Holdings
3.8%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
13,783
Price
$80.23
Total Value
$1.11M
Shares Held After
296,277
% of Holdings
4.4%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
331,979
Price
$1.66
Total Value
$550.69K
Shares Held After
7,447,000
% of Holdings
4.5%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
14,144
Price
$35.42
Total Value
$500.98K
Shares Held After
1,399,154
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
185,856
Price
$35.09
Total Value
$6.52M
Shares Held After
1,413,298
% of Holdings
11.6%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
1,684
Price
$29.89
Total Value
$50.34K
Shares Held After
445,215
% of Holdings
0.4%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
13,316
Price
$29.52
Total Value
$393.05K
Shares Held After
446,899
% of Holdings
2.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
100
Price
$24.85
Total Value
$2.48K
Shares Held After
377,802
% of Holdings
0.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,781
Price
$24.53
Total Value
$288.99K
Shares Held After
377,902
% of Holdings
3.0%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
55
Price
$79.95
Total Value
$4.40K
Shares Held After
13,257
% of Holdings
0.4%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
2,388
Price
$79.95
Total Value
$190.92K
Shares Held After
304,900
% of Holdings
0.8%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
2,869
Price
$79.95
Total Value
$229.38K
Shares Held After
310,060
% of Holdings
0.9%
Oric Pharmaceuticals, Inc. (ORIC)
Piscitelli Dominic — Chief Financial Officer
Shares
14,000
Price
$13.53
Total Value
$189.39K
Shares Held After
69,828
% of Holdings
16.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
221
Price
$563.56
Total Value
$124.55K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
464
Price
$562.78
Total Value
$261.13K
Shares Held After
324,664
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$561.84
Total Value
$202.26K
Shares Held After
325,128
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
315
Price
$560.67
Total Value
$176.61K
Shares Held After
325,488
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$559.70
Total Value
$156.72K
Shares Held After
325,803
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$558.72
Total Value
$290.54K
Shares Held After
326,083
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$557.12
Total Value
$178.28K
Shares Held After
326,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$556.06
Total Value
$244.67K
Shares Held After
326,923
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$555.09
Total Value
$88.81K
Shares Held After
327,363
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$553.97
Total Value
$698.00K
Shares Held After
327,523
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$553.14
Total Value
$132.75K
Shares Held After
328,783
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,560
Price
$551.85
Total Value
$860.88K
Shares Held After
329,023
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,134
Price
$551.03
Total Value
$624.87K
Shares Held After
330,583
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
586
Price
$550.02
Total Value
$322.31K
Shares Held After
331,717
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
948
Price
$548.95
Total Value
$520.40K
Shares Held After
332,303
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
575
Price
$547.79
Total Value
$314.98K
Shares Held After
333,251
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
117
Price
$546.84
Total Value
$63.98K
Shares Held After
333,826
% of Holdings
0.0%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
254,342
Price
$1.60
Total Value
$405.73K
Shares Held After
7,115,021
% of Holdings
3.6%
MeiraGTx Holdings plc (MGTX)
Giroux Richard — CFO&COO
Shares
56,000
Price
$9.95
Total Value
$557.20K
Shares Held After
852,530
% of Holdings
6.2%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,000
Price
$79.49
Total Value
$238.47K
Shares Held After
29,995
% of Holdings
9.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
4,100
Price
$78.79
Total Value
$323.04K
Shares Held After
32,995
% of Holdings
11.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
1,000
Price
$77.20
Total Value
$77.20K
Shares Held After
37,095
% of Holdings
2.6%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
500
Price
$76.12
Total Value
$38.06K
Shares Held After
38,095
% of Holdings
1.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
400
Price
$74.90
Total Value
$29.96K
Shares Held After
38,595
% of Holdings
1.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
220
Price
$2.37
Total Value
$521.40
Shares Held After
2,990,109
% of Holdings
0.0%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Soares Karen — Chief Legal Officer
Shares
19,275
Price
$4.66
Total Value
$89.82K
Shares Held After
1,573,423
% of Holdings
1.2%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$64.01
Total Value
$224.04K
Shares Held After
153,902
% of Holdings
2.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$24.05
Total Value
$285.74K
Shares Held After
377,802
% of Holdings
3.0%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
4,256
Price
$1.88
Total Value
$8.00K
Shares Held After
2,948,610
% of Holdings
0.1%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
5,000
Price
$38.47
Total Value
$192.34K
Shares Held After
25,000
% of Holdings
16.7%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
115
Price
$79.97
Total Value
$9.20K
Shares Held After
13,312
% of Holdings
0.9%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
4,942
Price
$79.97
Total Value
$395.21K
Shares Held After
307,288
% of Holdings
1.6%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
5,937
Price
$79.97
Total Value
$474.78K
Shares Held After
312,929
% of Holdings
1.9%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
6,018
Price
$38.48
Total Value
$231.55K
Shares Held After
38,000
% of Holdings
13.7%
1163 transactions